Dr. Bermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Building U10
Cleveland, OH 44195Phone+1 216-444-8600Fax+1 216-445-6259
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
FL State Medical License 2024 - 2026
NY State Medical License 2024 - 2025
OH State Medical License 2003 - 2025
NV State Medical License 2012 - 2023- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Optical Coherence Tomography in Multiple Sclerosis Patients Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.Xiaotong Jiang, Marisa McGinley, Joshua Johnston, Jay Alberts, Robert Bermel
Multiple Sclerosis. 2024-12-01 - Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.Scott D Newsome, Lawrence Goldstick, Derrick S Robertson, James D Bowen, Robert T Naismith
Annals of Clinical and Translational Neurology. 2024-12-01 - Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.Alex Ocampo, Farhad Hatami, Jelena Čuklina, Gordon Graham, Habib Ganjgahi
Multiple Sclerosis. 2024-10-01
Journal Articles
- Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients with Alzheimer's and Parkinson's DiseaseHubert Fernandez, Justis P Ehlers, Jagan A Pillai, Sunil K Srivastava, Robert Bermel, James B Leverenz, Investigative Ophthalmology and Visual Science
Authored Content
- Optical Coherence Tomography Outcomes from SPRINT-MS, a Multicenter, Randomized, Double-Blind Trial of Ibudilast in Progressive Multiple SclerosisOctober 2020
Press Mentions
How B-cell Therapy Affects MSFebruary 7th, 2023- World-First Study Charts Brain Decline as We AgeApril 7th, 2022
- ADEM After COVID-19 Vaccine: Case ReportSeptember 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
